N-acetylation of Hypothalamic Alpha-melanocyte-stimulating Hormone and Regulation by Leptin

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Jul 29

PMID 15280541

Citations 26

Authors

Li Guo

Heike Munzberg

Ronald C Stuart

Eduardo A Nillni

Christian Bjorbaek

Affiliations

Soon will be listed here.

Abstract

The central melanocortin system is critical in the regulation of appetite and body weight, and leptin exerts its anorexigenic actions partly by increasing hypothalamic proopiomelanocortin (POMC) expression. The POMC-derived peptide alpha-melanocyte-stimulating hormone (alphaMSH) is a melanocortin 4 receptor agonist, and its potency in reducing energy intake is strongly increased by N-acetylation. The reason for the higher biological activity of N-acetylated alphaMSH (Act-alphaMSH) compared with that of N-desacetylated alphaMSH (Des-alphaMSH) is unclear, and regulation of acetylation by leptin has not been investigated. We show here that total hypothalamic alphaMSH levels are decreased in leptin-deficient ob/ob mice and increased in leptin-treated ob/ob and C57BL/6J mice. The increase in total alphaMSH occurred as soon as 3 h after leptin injection and was entirely due to an increase in Act-alphaMSH. Consistent with this observation, leptin rapidly induced the enzymatic activity of a N-acetyltransferase in the hypothalamus of mice. In 293T cells expressing the melanocortin 4 receptor, Act-alphaMSH is far more potent than Des-alphaMSH in stimulating cAMP accumulation, an effect caused by a dramatically increased stability of Act-alphaMSH. Moreover, Des-alphaMSH is rapidly degraded in the hypothalamus after intracerebroventricular injection in rats and was less potent in inhibiting energy intake. The results suggest that leptin activates a N-acetyltransferase in POMC neurons, leading to increased hypothalamic levels of Act-alphaMSH. Due to its increased stability, this posttranslational modification of alphaMSH may play a critical role in leptin action via the central melanocortin pathway.

Citing Articles

Regulation of energy balance by leptin as an adiposity signal and modulator of the reward system.

Asgari R, Caceres-Valdiviezo M, Wu S, Hamel L, Humber B, Agarwal S Mol Metab. 2024; 91():102078.

PMID: 39615837 PMC: 11696864. DOI: 10.1016/j.molmet.2024.102078.

Impact of the Central Histaminergic and Melanocortin Systems on Leptin-Induced Hypophagia in Neonatal Layer Chicken.

Shalikar M, Zendehdel M, Vazir B, Asghari A Arch Razi Inst. 2022; 76(6):1735-1744.

PMID: 35546995 PMC: 9083869. DOI: 10.22092/ari.2021.354188.1626.

Genetic Deletion of KLHL1 Leads to Hyperexcitability in Hypothalamic POMC Neurons and Lack of Electrical Responses to Leptin.

Perissinotti P, Martinez-Hernandez E, He Y, Koob M, Piedras-Renteria E Front Neurosci. 2021; 15:718464.

PMID: 34566565 PMC: 8458657. DOI: 10.3389/fnins.2021.718464.

The melanocortin pathway and energy homeostasis: From discovery to obesity therapy.

Yeo G, Herrera Moro Chao D, Siegert A, Koerperich Z, Ericson M, Simonds S Mol Metab. 2021; 48:101206.

PMID: 33684608 PMC: 8050006. DOI: 10.1016/j.molmet.2021.101206.

Quantitative mass spectrometry for human melanocortin peptides in vitro and in vivo suggests prominent roles for β-MSH and desacetyl α-MSH in energy homeostasis.

Kirwan P, Kay R, Brouwers B, Herranz-Perez V, Jura M, Larraufie P Mol Metab. 2018; 17:82-97.

PMID: 30201275 PMC: 6197775. DOI: 10.1016/j.molmet.2018.08.006.

References

Pritchard L, Turnbull A, White A . Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol. 2002; 172(3):411-21. DOI: 10.1677/joe.0.1720411. View

Vaisse C, Clement K, Guy-Grand B, Froguel P . A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 1998; 20(2):113-4. DOI: 10.1038/2407. View

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J . Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372(6505):425-32. DOI: 10.1038/372425a0. View

Elmquist J . Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Int J Obes Relat Metab Disord. 2002; 25 Suppl 5:S78-82. DOI: 10.1038/sj.ijo.0801918. View

Schwartz M, Seeley R, Woods S, Weigle D, Campfield L, Burn P . Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 1997; 46(12):2119-23. DOI: 10.2337/diab.46.12.2119. View

Huszar D, Lynch C, Dunmore J, Fang Q, Berkemeier L, Gu W . Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997; 88(1):131-41. DOI: 10.1016/s0092-8674(00)81865-6. View

Vergoni A, Bertolini A . Role of melanocortins in the central control of feeding. Eur J Pharmacol. 2000; 405(1-3):25-32. DOI: 10.1016/s0014-2999(00)00538-0. View

Cheung C, Clifton D, Steiner R . Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology. 1997; 138(10):4489-92. DOI: 10.1210/endo.138.10.5570. View

Watanobe H, Habu S . Leptin regulates growth hormone-releasing factor, somatostatin, and alpha-melanocyte-stimulating hormone but not neuropeptide Y release in rat hypothalamus in vivo: relation with growth hormone secretion. J Neurosci. 2002; 22(14):6265-71. PMC: 6757925. DOI: 20026615. View

10.

Munzberg H, Huo L, Nillni E, Hollenberg A, Bjorbaek C . Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology. 2003; 144(5):2121-31. DOI: 10.1210/en.2002-221037. View

11.

Jegou S, Tranchand-Bunel D, Delbende C, Blasquez C, Vaudry H . Characterization of alpha-MSH-related peptides released from rat hypothalamic neurons in vitro. Brain Res Mol Brain Res. 1989; 5(3):219-26. DOI: 10.1016/0169-328x(89)90038-7. View

12.

Bjorbaek C, Elmquist J, Frantz J, Shoelson S, Flier J . Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell. 1998; 1(4):619-25. DOI: 10.1016/s1097-2765(00)80062-3. View

13.

Emeson R, Eipper B . Characterization of pro-ACTH/endorphin-derived peptides in rat hypothalamus. J Neurosci. 1986; 6(3):837-49. PMC: 6568456. View

14.

Abbott C, Rossi M, Kim M, alAhmed S, Taylor G, Ghatei M . Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor. Brain Res. 2000; 869(1-2):203-10. DOI: 10.1016/s0006-8993(00)02386-6. View

15.

Kask A, Rago L, Wikberg J, Schioth H . Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur J Pharmacol. 1998; 360(1):15-9. DOI: 10.1016/s0014-2999(98)00699-2. View

16.

ODonohue T, Handelmann G, Chaconas T, Miller R, Jacobowitz D . Evidence that N-acetylation regulates the behavioral activity of alpha-MSH in the rat and human central nervous system. Peptides. 1981; 2(3):333-44. DOI: 10.1016/s0196-9781(81)80126-x. View

17.

Marsh D, Hollopeter G, Huszar D, Laufer R, Yagaloff K, Fisher S . Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet. 1999; 21(1):119-22. DOI: 10.1038/5070. View

18.

Bergendahl M, Wiemann J, Clifton D, Huhtaniemi I, Steiner R . Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. Neuroendocrinology. 1992; 56(6):913-20. DOI: 10.1159/000126324. View

19.

Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A . Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998; 19(2):155-7. DOI: 10.1038/509. View

20.

Tsujii S, Bray G . Acetylation alters the feeding response to MSH and beta-endorphin. Brain Res Bull. 1989; 23(3):165-9. DOI: 10.1016/0361-9230(89)90142-1. View